Myriad Genetics |
Datum/Vreme | / |
Promena / Promena(%) | - / |
Tražnja | - |
Ponuda | - |
Cena na otvaranju | - |
Prethodno zatvaranje | - |
Najviša cena | - |
Najniža | - |
Obim [USD] | - |
Obim [Jedinice] | |
Dogovorena cena | |
ISIN | US62855J1043 |
Simbol | MYGN |
Berza | IEX |
Vrsta | Stock |
Druge berze
Berza | Poslednja cena | Obim | |
---|---|---|---|
NASDAQ | 22,0550 | ![]() |
65.684 |
Cboe US | 22,03 | ![]() |
7.033 |
IEX | 22,11 | ![]() |
3.600 |
Hannover | 21,330 | ![]() |
0 |
Frankfurt | 21,3200 | ![]() |
0 |
Berlin | 21,310 | ![]() |
0 |
München | 21,330 | ![]() |
0 |
Hamburg | 21,330 | ![]() |
0 |
Düsseldorf | 21,170 | ![]() |
0 |
Lang & Schwa.. | 21,170 | ![]() |
|
Stuttgart | 21,300 | ![]() |
|
gettex | 21,430 | ![]() |
|
Quotrix | 21,4300 | ![]() |
|
TradeGate | 19,025 | 400 | |
Xetra | 19,250 | 0 | |
London Domes.. | 23,39 | 140 |
Vesti
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Kliknite na
da aktivirate push kvote.
